Abstract
Background HIV and sickle cell disease (SCD) are significant causes of morbidity and mortality among pediatric populations in sub-Saharan Africa. They both, individually, adversely impact the immune system heightening the risk for severe infections. However, little is known on how these two chronic inflammatory illnesses interact. Objective To determine how SCD affects the HIV treatment outcomes including immunological, nutritional, hematological, change to 2nd line treatment and overall survival. Methods We did a retrospective cohort study on pediatric patients less than 19 years …
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
